Cargando…

The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave

Background: Due to the unclear protective role of produced antibodies and the need for seroepidemiologic studies, we surveyed the COVID-19 seroprevalence among healthcare professionals who had direct or indirect contact with COVID-19 patients. Methods: From 19 October 2020 to 17 February 2021, 300 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaezi, Atefeh, Fakhim, Hamed, Abbasi, Saeed, Masoudi, Soraya, Rizi, Mahnaz Hosseini, Haghjooy Javanmard, Shaghayegh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844358/
https://www.ncbi.nlm.nih.gov/pubmed/36648886
http://dx.doi.org/10.3390/antib12010002
_version_ 1784870635832344576
author Vaezi, Atefeh
Fakhim, Hamed
Abbasi, Saeed
Masoudi, Soraya
Rizi, Mahnaz Hosseini
Haghjooy Javanmard, Shaghayegh
author_facet Vaezi, Atefeh
Fakhim, Hamed
Abbasi, Saeed
Masoudi, Soraya
Rizi, Mahnaz Hosseini
Haghjooy Javanmard, Shaghayegh
author_sort Vaezi, Atefeh
collection PubMed
description Background: Due to the unclear protective role of produced antibodies and the need for seroepidemiologic studies, we surveyed the COVID-19 seroprevalence among healthcare professionals who had direct or indirect contact with COVID-19 patients. Methods: From 19 October 2020 to 17 February 2021, 300 healthcare workers were enrolled and tested for serum antibodies in this prospective cohort study. Demographic information, risk factors, and infection history were collected. Anti- SARS-CoV-2 IgG and IgM antibody titers were determined to estimate the seroconversion rate. Results: During the first and second phases of the study, the positive seroconversion rates were 31.7 and 26.6%, respectively. In seronegative individuals, sixteen (10.6%) new cases of COVID-19 and five (6.3%) reinfections were identified. Among those with a positive antibody level, forty-one (36.9%) healthcare workers reported no symptoms in the preceding months. There was no association between occupational exposure and an increased probability of seroconversion. Conclusions: The seropositivity rate and the rate of asymptomatic individuals with seroconversion was remarkable and could be an indicator of a high infection rate among healthcare workers.
format Online
Article
Text
id pubmed-9844358
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98443582023-01-18 The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave Vaezi, Atefeh Fakhim, Hamed Abbasi, Saeed Masoudi, Soraya Rizi, Mahnaz Hosseini Haghjooy Javanmard, Shaghayegh Antibodies (Basel) Article Background: Due to the unclear protective role of produced antibodies and the need for seroepidemiologic studies, we surveyed the COVID-19 seroprevalence among healthcare professionals who had direct or indirect contact with COVID-19 patients. Methods: From 19 October 2020 to 17 February 2021, 300 healthcare workers were enrolled and tested for serum antibodies in this prospective cohort study. Demographic information, risk factors, and infection history were collected. Anti- SARS-CoV-2 IgG and IgM antibody titers were determined to estimate the seroconversion rate. Results: During the first and second phases of the study, the positive seroconversion rates were 31.7 and 26.6%, respectively. In seronegative individuals, sixteen (10.6%) new cases of COVID-19 and five (6.3%) reinfections were identified. Among those with a positive antibody level, forty-one (36.9%) healthcare workers reported no symptoms in the preceding months. There was no association between occupational exposure and an increased probability of seroconversion. Conclusions: The seropositivity rate and the rate of asymptomatic individuals with seroconversion was remarkable and could be an indicator of a high infection rate among healthcare workers. MDPI 2022-12-23 /pmc/articles/PMC9844358/ /pubmed/36648886 http://dx.doi.org/10.3390/antib12010002 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vaezi, Atefeh
Fakhim, Hamed
Abbasi, Saeed
Masoudi, Soraya
Rizi, Mahnaz Hosseini
Haghjooy Javanmard, Shaghayegh
The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title_full The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title_fullStr The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title_full_unstemmed The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title_short The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
title_sort seroprevalence and seropositivity of sars-cov-2 among healthcare workers during the third pandemic wave
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844358/
https://www.ncbi.nlm.nih.gov/pubmed/36648886
http://dx.doi.org/10.3390/antib12010002
work_keys_str_mv AT vaeziatefeh theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT fakhimhamed theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT abbasisaeed theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT masoudisoraya theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT rizimahnazhosseini theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT haghjooyjavanmardshaghayegh theseroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT vaeziatefeh seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT fakhimhamed seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT abbasisaeed seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT masoudisoraya seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT rizimahnazhosseini seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave
AT haghjooyjavanmardshaghayegh seroprevalenceandseropositivityofsarscov2amonghealthcareworkersduringthethirdpandemicwave